Waddill William D.
- SEC CIK
- 0001553338
In the past year, 6 open-market sale filings worth $6.15M and no purchases.
Current role at each company
- PTGX Protagonist Therapeutics, IncDirectoras of Jun 25, 2026
- ANNX Annexon, Inc.Directoras of Jun 15, 2026
- ARWR Arrowhead Pharmaceuticals, Inc.Directoras of Dec 23, 2025
- TSBX Turnstone Biologics Corp.Directoras of Jul 2, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $6.15M
- 6 filings
- Net
- −$6.15M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Waddill William D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PTGX Protagonist Therapeutics, Inc
Director12 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 (view filing) | Mar 1 | Same day | Waddill William D.Director | SSale | −13.0K | $31.34 | −$406.6K | −52.0%12.0K after | 10b5-1 |
| Jun 11, 2024 (view filing) | Jun 7 | 4 days | Waddill William D.Director | SSale | −8.00K | $35.00 | −$280.0K | −40.0%12.0K after | 10b5-1 |
| Jul 26, 2024 (view filing) | Jul 24 | 2 days | Waddill William D.Director | SSale | −8.00K | $40.00 | −$320.0K | −40.0%12.0K after | 10b5-1 |
| Sep 12, 2024 (view filing) | Sep 10 | 2 days | Waddill William D.Director | SSale | −8.00K | $45.00 | −$360.0K | −40.0%12.0K after | 10b5-1 |
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Waddill William D.Director | SSale | −4.00K | $54.25 | −$217.0K | −23.4%13.1K after | 10b5-1 |
| Aug 29, 2025 (view filing) | Aug 27 | 2 days | Waddill William D.Director | SSale | −4.00K | $59.25 | −$237.0K | −30.5%9.13K after | 10b5-1 |
| Sep 24, 2025 (view filing) | Sep 22 | 2 days | Waddill William D.Director | SSale | −4.00K | $64.25 | −$257.0K | −43.8%5.13K after | 10b5-1 |
| Oct 14, 2025 (view filing) | Oct 10 | 4 days | Waddill William D.Director | SSale | −12.0K | $81.62 | −$979.5K | −70.1%5.13K after | 2 lots10b5-1 |
| Feb 6, 2026 (view filing) | Feb 6 | Same day | Waddill William D.Director | SSale | −20.0K | $83.68 | −$1.67M | −71.9%7.83K after | |
| Jun 1, 2026 (view filing) | May 29 | 3 days | Waddill William D.Director | SSale | −9.00K | $99.64 | −$896.8K | −53.5%7.83K after | 10b5-1 |
ARWR Arrowhead Pharmaceuticals, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 (view filing) | Jan 3 | 1 day | Waddill William D.Director | SSale | −4.50K | $64.72 | −$291.2K | −14.9%25.8K after | 3 lots |
| Jan 11, 2023 (view filing) | Jan 9 | 2 days | Waddill William D.Director | SSale | −3.20K | $30.00 | −$96.0K | −10.0%28.9K after | |
| Jan 16, 2024 (view filing) | Jan 11 | 5 days | Waddill William D.Director | SSale | −3.93K | $38.07 | −$149.8K | −7.6%47.9K after | 2 lots10b5-1 |
| Dec 18, 2024 (view filing) | Dec 16-17 | 2 days | Waddill William D.Director | SSale | −7.50K | $21.97 | −$164.7K | −15.7%40.4K after | 2 lots10b5-1 |
| Dec 23, 2025 (view filing) | Dec 19 | 4 days | Waddill William D.Director | SSale | −8.37K | $67.65 | −$566.0K | −12.9%56.6K after | 3 lots10b5-1 |